To confirm our microarray analysis, RT-qPCR was performed on EpCAM-positive cells sorted from an independent set of DCIS cell line MIND xenografts as they progressed from 2 to 10 weeks. The gene discussed is EPCAM; the disease is ductal breast carcinoma in situ.